Ramsay Generale de Sante SA (XPAR:GDS)

€ 11.3 -0.55 (-4.64%) Market Cap: 1.25 Bil Enterprise Value: 4.92 Bil PE Ratio: 0 PB Ratio: 1.09 GF Score: 59/100

Half Year 2024 Ramsay Generale de Sante SA Earnings Call Transcript
Feb 28, 2024

€17.9

Earnings
Half Year 2022 Ramsay Generale de Sante SA Earnings Call Transcript
Feb 23, 2022

€22.5

Earnings
Full Year 2021 Ramsay Generale de Sante SA Earnings Call Transcript
Aug 25, 2021

€19 (+1.33%)

Earnings
Half Year 2020 Ramsay Generale de Sante SA Earnings Call Transcript
Feb 26, 2020

€19.6 (+3.16%)

Earnings
Full Year 2019 Ramsay Generale de Sante SA Earnings Call Transcript
Aug 28, 2019

€18.7

Earnings

Half Year 2022 Ramsay Generale de Sante SA Earnings Call Transcript

Feb 23, 2022 / 06:30PM GMT

Release Date Price: €22.5

Transcript

Craig Ralph McNally;nÃ;rale de SantÃ;SA;Chairman

Ramsay GÃ

©©©-

Good morning, everyone, and thank you for joining us for our FY '22 half year results presentation webcast. My name is Craig McNally, and I'm the Managing Director and CEO of Ramsay Health Care; and I'm joined by Martyn Roberts, our Group Chief Financial Officer. Today, we will provide an overview of our performance for the 6-month period and a brief update on our strategy, including the recently completed acquisition of Elysium Healthcare, before covering off on the outlook for the group.

Moving to an overview of the 6-month period. As we highlighted in our November update, the COVID environment has continued to impact our activities with further waves of the virus resulting in government-mandated restrictions on capacity utilization and a material impact on the availability of our people, doctors and patients, driving significant disruption in our operating environment and higher costs. Importantly, underlying demand for health care services remains strong in all our

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.